| Molecular formula: C5H12O4 | Molecular weight: 136.17 |

The single dose toxicity test revealed LD50 values of above 2000 mg/kg for both sexes.
In the repeat dose toxicity test, soft feces and diarrhea were observed in both sexes of the 300 and 1000 mg/kg groups and an increase in water consumption was observed in males of the 1000 mg/kg group. The NOELs for repeat dose toxicity for both sexes are considered to be 100 mg/kg/day. No effects were observed on reproductive performance in either sex or on development of the next generation. The NOELs for reproductive and developmental performances are considered to be over 1000 mg/kg/day.
Pentaerythritol was not mutagenic in Salmonella typhimurium TA100, TA98, TA1535, TA1537 and Escherichia coli WP2 uvrA.
Neither structural chromosomal aberrations nor polyploidy were induced in CHL/IU cells up to the limit concentration of 10 mM, in the absence or presence of an exogenous metabolic activation system.
| Purity | : | 92.7% |
| Test species/strain | : | Rat/Crj:CD (SD) |
| Test method | : | OECD Test Guideline 401 |
| Dosage | : | 500, 1000, 2000 mg/kg |
| Number of animals | : | Male, 5; female, 5/group |
| GLP | : | Yes |
| Purity | : | 92.7% |
| Test species/strain | : | Rat/Crj:CD (SD) |
| Test method | : | OECD Combined Repeat Dose and Reproductive/ Developmental Toxicity Screening Test |
| Route | : | Oral (gavage) |
| Dosage | : | 0 (vehicle), 100, 300, 1000 mg/kg/day |
| Number of animals | : | Males, 12; females, 12/group |
| Vehicle | : | 0.5% CMC-Na solution |
| Administration period | : | Males, 46 days Females, from 14 days before mating to Day 3 of lactation |
| Terminal kill | : | Males, day 47 Females, day 4 of lactation |
| GLP | : | Yes |
Test results:
| Purity | : | 92.7% |
| Test species/strains | : | S.typhimurium TA100, TA1535, TA98, TA1537 E. coli WP2 uvrA (SD) |
| Test methods | : | Guideline for Screening Mutagenicity Testing of Chemicals (Japan) |
| Procedures | : | Plate incorporation method |
| Solvent | : | Pure water |
| Positive controls | : | -S9, AF-2 (TA100, WP2, TA98), sodium azide (TA1535) and 9-aminoacridine (TA1537) |
| +S9, 2-aminoanthracene (all strains) | ||
| Doses | : | 0, 312.5, 625, 1250, 2500, 5000 μg/plate |
| S-9 | : | Rat liver, induced with phenobarbital and 5,6-benzoflavone |
| Plates/test | : | 3 |
| Number of replicates | : | 2 |
| GLP | : | Yes |
| + | ? | - | |
| without metabolic activation: | [ ] | [ ] | [*] |
| with metabolic activation: | [ ] | [ ] | [*] |
| + | ? | - | |
| without metabolic activation: | [ ] | [ ] | [*] |
| with metabolic activation: | [ ] | [ ] | [*] |
| Purity | : | 92.7% |
| Type of cell used | : | Chinese hamster lung (CHL/IU) cells |
| Test method | : | Guidelines for Screening Mutagenicity Testings of Chemicals (Japan) |
| Solvent | : | Water for injection |
| Positive controls | : | -S9, Mitomycin C +S9, Cyclophosphamide |
| Doses | : | -S9 (continuous treatment): 0, 0.4, 0.7, 1.4 mg/ml -S9 (short-term treatment): 0, 0.4, 0.7, 1.4 mg/ml +S9 (short-term treatment): 0, 0.4, 0.7, 1.4 mg/ml |
| S-9 | : | Rat liver, induced with phenobarbital and 5,6-benzoflavone |
| Plates/test | : | 2 |
| GLP | : | Yes |
| clastogenicity | polyploidy | |||||
| + | ? | - | + | ? | - | |
| without metabolic activation: | [ ] | [ ] | [*] | [ ] | [ ] | [*] |
| with metabolic activation: | [ ] | [ ] | [*] | [ ] | [ ] | [*] |
| 1) | The tests were performed by the Safety Research Institute for Chemical Compounds Co., Ltd., 363-24, Shin-ei, Toyohira-ku, Sapporo, Hokkaido, 004, Japan. Tel +81-11-885-5031 Fax +81-11-885-5313 |
| 2) | The tests were performed by the Hatano Research Institute, Food and Drug Safety Center, 729-5 Ochiai, Hadano-shi, Kanagawa, 257, Japan. Tel +81-463-82-4751 Fax +81-463-82-9627 |